Published • loading... • Updated
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
The deal would add physician-distributed skincare brands to Galderma’s portfolio as it expands in the U.S. market.
- On Tuesday, Swiss skincare conglomerate Galderma agreed to acquire ZO Skin Health in an all-cash transaction valued at approximately $1.5 billion.
- Investment firm Blackstone, which acquired the Irvine, California-based brand in 2020, explored the sale with investment banks Citigroup and Raymond James.
- Founded by dermatologist Dr. Zein Obagi, ZO recorded net sales of approximately 330 million USD in the last 12 months as of June 2026.
- Galderma plans to integrate the brand into its Dermatological Skincare portfolio, complementing existing Alastin Skincare and Cetaphil products.
- The transaction is expected to close in the fourth quarter of 2026 or early 2027, with Galderma planning to increase commercial investment to strengthen future growth.
Insights by Ground AI
16 Articles
16 Articles
Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say - Regional Media News
By Abigail Summerville NEW YORK, Oct 13 (Reuters) - Swiss skincare conglomerate Galderma has agreed to buy medical-grade skincare company ZO Skin Health for around $1.5 billion, according to two people familiar with the matter. A deal could be announced in the coming days, the [...]
Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say
By Abigail Summerville NEW YORK, Oct 13 (Reuters) - Swiss skincare conglomerate Galderma has agreed to buy medical-grade skincare company ZO Skin Health for around $1.5 billion, according to two people familiar with the matter. A deal could be announ...
Coverage Details
Total News Sources16
Leaning Left0Leaning Right3Center4Last UpdatedBias Distribution57% Center
Bias Distribution
- 57% of the sources are Center
57% Center
C 57%
R 43%
Factuality
To view factuality data please Upgrade to Premium
